[11] Research published in the Journal of Physiology Paris found BPC 157 to have comparable effects to antidepressants, with no side effects
Though inherently microscopic in scale, this field is highly consequential, particularly because modern drug development largely revolves around identifying compounds that target specific proteins
Researchers have also explored DSIPs possible role in stress regulation, hormone signaling, and pain modulation, but the overall evidence remains preliminary and insufficient for definitive clinical recommendations
Priming with a combination of FGF2 and HGF restores the impaired osteogenic differentiation of adipose-derived stem cells
Novel therapy targeting for c-Met and EPCAM C-Met and novel therapy Anti-c-Met agents can be classified into four types: selective c-Met tyrosine kinase inhibitors (TKIs), non-selective c-Met inhibitors, monoclonal antibodies against HGF/c-Met, and microRNAs (miRNAs)